Abbott Laboratories (ABT) Social Stream



Abbott Laboratories (ABT): $103.44

-1.97 (-1.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ABBOTT LABORATORIES (ABT) Price Targets From Analysts

Use the tables below to see what analysts covering ABBOTT LABORATORIES think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 14 $146 $125 $137.166 $107.58 27.5%
2021-12-10 15 $146 $125 $137.846 $107.58 28.13%
2021-12-22 14 $150 $125 $138.583 $107.58 28.82%
2022-01-24 14 $157 $125 $140.333 $107.58 30.45%
2022-01-27 14 $151 $125 $139.25 $107.58 29.44%
2022-04-11 14 $151 $125 $139.307 $107.58 29.49%
2022-04-14 14 $151 $125 $140.461 $107.58 30.56%
2022-05-18 14 $151 $125 $139.846 $107.58 29.99%
2022-06-07 10 $150 $125 $140.636 $107.58 30.73%
2022-06-13 10 $150 $125 $139.727 $107.58 29.88%
2022-07-22 12 $150 $95 $127.083 $107.58 18.13%
2022-09-28 13 $150 $95 $127.153 $107.58 18.19%
2022-10-05 13 $150 $95 $126.692 $107.58 17.77%
2022-10-11 15 $144 $95 $125.461 $107.58 16.62%
2022-10-12 15 $144 $95 $124.357 $107.58 15.59%
2022-10-18 15 $144 $95 $124.142 $107.58 15.4%
2022-10-21 16 $144 $95 $122.333 $107.58 13.71%
2022-10-26 16 $140 $95 $117.466 $107.58 9.19%

The Trend in the Analyst Price Target


Over the past 21 months, ABT's average price target has gone down $4.35.

Over the past 46 weeks, ABT's average upside potential has been 19.68%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-22 14 150 125 138.583 138.99 -0.29%
2022-01-11 14 157 125 140.333 135.70 3.41%
2022-04-04 14 151 125 139.307 118.88 17.18%
2022-09-13 13 150 95 127.153 105.84 20.14%
2022-10-18 15 144 95 124.142 104.98 18.25%

ABT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.38 12 2 2 0 0 16

The Trend in the Broker Recommendations


ABT's average broker recommendation rating improved by 0.61 over the prior 13 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ABBOTT LABORATORIES's average analyst price target is higher than 2778.19% of Pharmaceutical Products stocks.
  • In terms of how ABBOTT LABORATORIES fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 2772.47% of that group.
  • ABT has a higher upside potential (average analyst target price relative to current price) than 528.4% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, ABBOTT LABORATORIES's variance in analysts' estimates is lower than -464.51% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ABBOTT LABORATORIES are BNTX, MRNA, and GILD.

Make investment decisions regarding ABT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7525 seconds.